Suppr超能文献

关于一种用于皮肤紧致的宽带红外光设备的多中心临床观点。

Multicenter clinical perspectives on a broadband infrared light device for skin tightening.

作者信息

Taub Amy Forman, Battle Eliot F, Nikolaidis Gregory

机构信息

Advanced Dermatology, Lincolnshire, IL 60069, USA.

出版信息

J Drugs Dermatol. 2006 Sep;5(8):771-8.

Abstract

Modalities for skin tightening include radiofrequency (RF) energy, lasers, and combination RF and diode lasers. A new broadband infrared light device (BILD) (Titan, Cutera, Inc, Brisbane, CA) targets water to achieve dermal heating and collagen remodeling for skin tightening. Although thousands of procedures have been performed worldwide with this device, only one article (to the author's knowledge) describing its performance in skin tightening has been published. Three US dermatologists report their experience with and provide their perspective on facial skin tightening with the BILD system. As early adopters, they each have 12 to 18 months experience with this system. One author (A.F.T.) treated 42 patients twice at 1-month intervals over 18 months. The mean improvement score was 1.83 (scale 0 to 4, with 4 denoting maximum improvement) with an average follow-up time of 3.7 months. More than 90% of treated patients showed visible improvement. No complications were observed and patient satisfaction was high. This paper presents the general consensus of the authors on patient selection and treatment protocol, their modifications of the manufacturer's treatment protocol, and the outcomes of 42 patients treated by one author (A.F.T.). The observations were gathered separately and turned out to be very similar. The recommendations are presented to help practitioners achieve consistently good results and avoid complications with the BILD procedure.

摘要

皮肤紧致的治疗方式包括射频(RF)能量、激光以及射频与二极管激光联合治疗。一种新型宽带红外光设备(BILD)(Titan,Cutera公司,加利福尼亚州布里斯班)通过作用于水分来实现真皮层加热和胶原蛋白重塑,从而达到皮肤紧致的效果。尽管该设备在全球范围内已进行了数千例治疗,但据作者所知,仅有一篇文章发表描述其在皮肤紧致方面的表现。三位美国皮肤科医生报告了他们使用BILD系统进行面部皮肤紧致治疗的经验,并给出了他们的观点。作为早期使用者,他们每人都有12至18个月使用该系统的经验。一位作者(A.F.T.)在18个月内分两次、间隔1个月对42名患者进行了治疗。平均改善评分为1.83(评分范围0至4,4表示最大改善),平均随访时间为3.7个月。超过90%的接受治疗患者有明显改善。未观察到并发症,患者满意度较高。本文介绍了作者们在患者选择和治疗方案、对制造商治疗方案的修改以及一位作者(A.F.T.)治疗的42名患者的治疗结果方面的总体共识。这些观察结果是分别收集的,结果非常相似。文中给出这些建议是为了帮助从业者在使用BILD治疗时持续取得良好效果并避免并发症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验